Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 198-204

  Wang, Shujing ^a   Sun, Minjie ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Absorption enhancing mechanism; Bioavailability; Hydroxysafflor yellow A; Labrafac Lipophile WL 1349

Indexed keywords

DECANOIC ACID; DECANOIC ACID DERIVATIVE; DEOXYCHOLIC ACID; FATTY ACID; HYDROXYSAFFLOR YELLOW A; LABRAFAC LIPOPHILE WL 1349; MONOACYLGLYCEROL; OCTANOIC ACID; OCTANOIC ACID DERIVATIVE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; PLANT EXTRACT; SURFACTANT; TRIACYLGLYCEROL LIPASE; WL 1349;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BILE DUCT LIGATION; CLASSIFICATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HYDROLYSIS; DRUG SOLUBILITY; IN VITRO STUDY; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BILE DUCTS; BIOLOGICAL AVAILABILITY; CHALCONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCIPIENTS; HALF-LIFE; LIGATION; LIPOLYSIS; MALE; OILS; PHARMACEUTICAL SOLUTIONS; PHOSPHOLIPIDS; QUINONES; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 44449083180     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.03.006     Document Type: Article

References (24)

1. Constantinides P.P., Scalart J.-P., Lancaster C., Marcello J., Marks G., Ellens H., and Smith P.L. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res. 11 (1994) 1385-1390
2. Constantinides P.P., Welzel G., Ellens H., Smith P.L., Sturgis S., Yiv S.H., and Owen A.B. Water-in-oil microemulsions containing medium-chain fatty acids/salt: formulation and intestinal absorption enhancement evaluation. Pharm. Res. 13 (1996) 210-215
3. Dahan A., and Hoffman A. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur. J. Pharm. Biopharm. 67 (2007) 96-105
4. Devani M.J., Ashford M., and Craig D.Q.M. The development and characterisation of triglyceride-based 'spontaneous' multiple emulsions. Int. J. Pharm. 300 (2005) 76-88
5. Fernandez S., Jannin V., Rodier J.-D., Ritter N., Mahler B., and Carrière F. Comparative study on digestive lipase activities on the self-emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim. Biophys. Acta 1771 (2007) 633-640
6. Grove M., Müllertz A., Nielsen J.L., and Pedersen G.P. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur. J. Pharm. Sci. 28 (2006) 233-242
7. Grove M., Müllertz A., Pedersen G.P., and Nielsen J.L. Bioavailability of seocalcitol III: administration of lipid-based formulations to minipigs in the fasted and fed state. Eur. J. Pharm. Sci. 31 (2007) 8-15
8. Hauss D.J. Oral lipid-based formulations. Adv. Drug Deliv. Rev. 59 (2007) 667-676
9. Lee T.-Y., Chang H.-H., Chen J.-H., Hsueh M.-L., and Kuo J.-J. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J. Ethnopharmacol. 109 (2007) 318-324
10. Legen I., Salobir M., and Kerč J. Comparison of different intestinal epithelia as models for absorption enhancement studies. Int. J. Pharm. 291 (2005) 183-188
11. Ljusberg-Wahren H., Nielsen F.S., Brogård M., Troedsson E., and Müllertz A. Enzymatic characterization of lipid-based drug delivery systems. Int. J. Pharm. 298 (2005) 328-332
12. Liu Z., Li C., Li M., Li D., and Liu K. The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats. Toxicology 203 (2004) 139-143
13. Liu Z., Liang X., Li C., and Liu K. The hydroxysafflor yellow A could inhibit the serum matrix metalloproteinase in pressure over-loaded hypertrophy SD rats. J. Mol. Cell. Cardiol. 40 (2006) 885
14. Miyake M., Minami T., Toguchi H., Odomi M., Ogawara K., Higaki K., and Kimura T. Importance of bile acids for novel oral absorption system containing polyamines to improve intestinal absorption. J. Control. Release 115 (2006) 130-133
15. New R.R.C., and Kirby C.J. Solubilisation of hydrophilic drugs in oily formulations. Adv. Drug Deliv. Rev. 25 (1997) 59-69
16. Prasad Y.V.R., Eaimtrakarn S., Ishida M., Kusawake Y., Tawa R., Yoshikawa Y., Shibata N., and Takada K. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int. J. Pharm. 268 (2003) 13-21
17. Prasad Y.V.R., Puthli S.P., Eaimtrakarn S., Ishida M., Yoshikawa Y., Shibata N., and Takada K. Enhanced intestinal absorption of vancomycin with Labrasol and d-α-tocopheryl PEG 1000 succinate in rats. Int. J. Pharm. 250 (2003) 181-190
18. Sharma P., Varma M.V.S., Chawla H.P.S., and Panchagnula R. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Il Farmaco 60 (2005) 884-893
19. Shi M. The application of safflower injection in clinical. Mod. J. Integr. Tradit. Chin West. Med. 28 (2004) 937-939
20. Tavakoli S., Hajrasouliha A.R., Jabehdar-Maralani P., Ebrahimi F., Sadeghipour H., Dehghani M., Shafaroodi H., and Dehpour A.R. Modulated hemodynamic response to clonidine in bile duct-ligated rats: the role of nitric oxide. Eur. J. Pharmacol. 542 (2006) 148-153
21. Wang T., Fu F., Han B., and Zhang L. Mechanism of hydroxysafflor yellow A on protecting ischemic myocardium. J. Mol. Cell. Cardiol. 40 (2006) 957
22. Wei X., Liu H., Sun X., Fu F., Zhang X., Wang J., An J., and Ding H. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci. Lett. 386 (2005) 58-62
23. Yanyu X., Yunmei S., Zhipeng C., and Qineng P. The preparation of silybin-phopspholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm. 307 (2006) 77-82
24. Zhang H.F., Guo J.X., Hang L.S., and Ping Q.N. Absorption mechanism of hydroxysafflor yellow A in rats. J. Chin. Pharm. Univ. 37 (2006) 312-317